Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein

Jeroen R P M Strating, Lonneke van der Linden, Lucian Albulescu, Joëlle Bigay, Minetaro Arita, Leen Delang, Pieter Leyssen, Hilde M. van der Schaar, Kjerstin H W Lanke, Hendrik Jan Thibaut, Rachel Ulferts, Guillaume Drin, Nina Schlinck, Richard W. Wubbolts, Navdar Sever, Sarah A. Head, Jun Liu, Philip A. Beachy, Maria A. DeMatteis, Matthew D. ShairVesa M. Olkkonen, Johan Neyts, Frank J M van Kuppeveld

Research output: Contribution to journalArticle

Abstract

Itraconazole (ITZ) is a well-known antifungal agent that also has anticancer activity. In this study, weidentify ITZ as a broad-spectrum inhibitor of enteroviruses (e.g., poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We demonstrate that ITZ inhibits viral RNA replication by targeting oxysterol-binding protein (OSBP) and OSBP-related protein 4 (ORP4). Consistently, OSW-1, a specific OSBP/ORP4 antagonist, also inhibits enterovirus replication. Knockdown of OSBP inhibits virus replication, whereas overexpression of OSBP or ORP4 counteracts the antiviral effects of ITZ and OSW-1. ITZ binds OSBP and inhibits its function, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thereby likely perturbing the virus-induced membrane alterations essential for viral replication organelle formation. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an essential role of OSBP/ORP4-mediated lipid exchange in virus replication that can be targeted by antiviral drugs.

Original languageEnglish (US)
Pages (from-to)600-615
Number of pages16
JournalCell Reports
Volume10
Issue number4
DOIs
StatePublished - Feb 3 2015

Fingerprint

Itraconazole
Enterovirus
Viruses
Virus Replication
Antiviral Agents
Proteins
Membranes
oxysterol binding protein
Rhinovirus
Poliovirus
Antifungal Agents
Viral RNA
Protein Binding
Hepacivirus
Organelles
Cholesterol
Lipids

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Strating, J. R. P. M., van der Linden, L., Albulescu, L., Bigay, J., Arita, M., Delang, L., ... van Kuppeveld, F. J. M. (2015). Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Reports, 10(4), 600-615. https://doi.org/10.1016/j.celrep.2014.12.054

Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. / Strating, Jeroen R P M; van der Linden, Lonneke; Albulescu, Lucian; Bigay, Joëlle; Arita, Minetaro; Delang, Leen; Leyssen, Pieter; van der Schaar, Hilde M.; Lanke, Kjerstin H W; Thibaut, Hendrik Jan; Ulferts, Rachel; Drin, Guillaume; Schlinck, Nina; Wubbolts, Richard W.; Sever, Navdar; Head, Sarah A.; Liu, Jun; Beachy, Philip A.; DeMatteis, Maria A.; Shair, Matthew D.; Olkkonen, Vesa M.; Neyts, Johan; van Kuppeveld, Frank J M.

In: Cell Reports, Vol. 10, No. 4, 03.02.2015, p. 600-615.

Research output: Contribution to journalArticle

Strating, JRPM, van der Linden, L, Albulescu, L, Bigay, J, Arita, M, Delang, L, Leyssen, P, van der Schaar, HM, Lanke, KHW, Thibaut, HJ, Ulferts, R, Drin, G, Schlinck, N, Wubbolts, RW, Sever, N, Head, SA, Liu, J, Beachy, PA, DeMatteis, MA, Shair, MD, Olkkonen, VM, Neyts, J & van Kuppeveld, FJM 2015, 'Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein', Cell Reports, vol. 10, no. 4, pp. 600-615. https://doi.org/10.1016/j.celrep.2014.12.054
Strating JRPM, van der Linden L, Albulescu L, Bigay J, Arita M, Delang L et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Reports. 2015 Feb 3;10(4):600-615. https://doi.org/10.1016/j.celrep.2014.12.054
Strating, Jeroen R P M ; van der Linden, Lonneke ; Albulescu, Lucian ; Bigay, Joëlle ; Arita, Minetaro ; Delang, Leen ; Leyssen, Pieter ; van der Schaar, Hilde M. ; Lanke, Kjerstin H W ; Thibaut, Hendrik Jan ; Ulferts, Rachel ; Drin, Guillaume ; Schlinck, Nina ; Wubbolts, Richard W. ; Sever, Navdar ; Head, Sarah A. ; Liu, Jun ; Beachy, Philip A. ; DeMatteis, Maria A. ; Shair, Matthew D. ; Olkkonen, Vesa M. ; Neyts, Johan ; van Kuppeveld, Frank J M. / Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. In: Cell Reports. 2015 ; Vol. 10, No. 4. pp. 600-615.
@article{5939727d4fad48eb9591ba99c5849a69,
title = "Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein",
abstract = "Itraconazole (ITZ) is a well-known antifungal agent that also has anticancer activity. In this study, weidentify ITZ as a broad-spectrum inhibitor of enteroviruses (e.g., poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We demonstrate that ITZ inhibits viral RNA replication by targeting oxysterol-binding protein (OSBP) and OSBP-related protein 4 (ORP4). Consistently, OSW-1, a specific OSBP/ORP4 antagonist, also inhibits enterovirus replication. Knockdown of OSBP inhibits virus replication, whereas overexpression of OSBP or ORP4 counteracts the antiviral effects of ITZ and OSW-1. ITZ binds OSBP and inhibits its function, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thereby likely perturbing the virus-induced membrane alterations essential for viral replication organelle formation. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an essential role of OSBP/ORP4-mediated lipid exchange in virus replication that can be targeted by antiviral drugs.",
author = "Strating, {Jeroen R P M} and {van der Linden}, Lonneke and Lucian Albulescu and Jo{\"e}lle Bigay and Minetaro Arita and Leen Delang and Pieter Leyssen and {van der Schaar}, {Hilde M.} and Lanke, {Kjerstin H W} and Thibaut, {Hendrik Jan} and Rachel Ulferts and Guillaume Drin and Nina Schlinck and Wubbolts, {Richard W.} and Navdar Sever and Head, {Sarah A.} and Jun Liu and Beachy, {Philip A.} and DeMatteis, {Maria A.} and Shair, {Matthew D.} and Olkkonen, {Vesa M.} and Johan Neyts and {van Kuppeveld}, {Frank J M}",
year = "2015",
month = "2",
day = "3",
doi = "10.1016/j.celrep.2014.12.054",
language = "English (US)",
volume = "10",
pages = "600--615",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein

AU - Strating, Jeroen R P M

AU - van der Linden, Lonneke

AU - Albulescu, Lucian

AU - Bigay, Joëlle

AU - Arita, Minetaro

AU - Delang, Leen

AU - Leyssen, Pieter

AU - van der Schaar, Hilde M.

AU - Lanke, Kjerstin H W

AU - Thibaut, Hendrik Jan

AU - Ulferts, Rachel

AU - Drin, Guillaume

AU - Schlinck, Nina

AU - Wubbolts, Richard W.

AU - Sever, Navdar

AU - Head, Sarah A.

AU - Liu, Jun

AU - Beachy, Philip A.

AU - DeMatteis, Maria A.

AU - Shair, Matthew D.

AU - Olkkonen, Vesa M.

AU - Neyts, Johan

AU - van Kuppeveld, Frank J M

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Itraconazole (ITZ) is a well-known antifungal agent that also has anticancer activity. In this study, weidentify ITZ as a broad-spectrum inhibitor of enteroviruses (e.g., poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We demonstrate that ITZ inhibits viral RNA replication by targeting oxysterol-binding protein (OSBP) and OSBP-related protein 4 (ORP4). Consistently, OSW-1, a specific OSBP/ORP4 antagonist, also inhibits enterovirus replication. Knockdown of OSBP inhibits virus replication, whereas overexpression of OSBP or ORP4 counteracts the antiviral effects of ITZ and OSW-1. ITZ binds OSBP and inhibits its function, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thereby likely perturbing the virus-induced membrane alterations essential for viral replication organelle formation. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an essential role of OSBP/ORP4-mediated lipid exchange in virus replication that can be targeted by antiviral drugs.

AB - Itraconazole (ITZ) is a well-known antifungal agent that also has anticancer activity. In this study, weidentify ITZ as a broad-spectrum inhibitor of enteroviruses (e.g., poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We demonstrate that ITZ inhibits viral RNA replication by targeting oxysterol-binding protein (OSBP) and OSBP-related protein 4 (ORP4). Consistently, OSW-1, a specific OSBP/ORP4 antagonist, also inhibits enterovirus replication. Knockdown of OSBP inhibits virus replication, whereas overexpression of OSBP or ORP4 counteracts the antiviral effects of ITZ and OSW-1. ITZ binds OSBP and inhibits its function, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thereby likely perturbing the virus-induced membrane alterations essential for viral replication organelle formation. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an essential role of OSBP/ORP4-mediated lipid exchange in virus replication that can be targeted by antiviral drugs.

UR - http://www.scopus.com/inward/record.url?scp=84922769738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922769738&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2014.12.054

DO - 10.1016/j.celrep.2014.12.054

M3 - Article

C2 - 25640182

AN - SCOPUS:84922769738

VL - 10

SP - 600

EP - 615

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 4

ER -